Basem Goueli is an Oncology physician affiliated with St. Luke's Hospital. OpenAlex indexes 9 publications with 1,021 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
45 Spindrift Dr
Williamsville, NY 142217889
Telephone
716-422-5422Registry record last updated 11 Oct 2019.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20241 payment
- Janssen Biotech, Inc.Program year20248 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
25.8%Opioid Agonist12.5%Oxycodone-Acetaminophen59%Fentanyl27%Hydromorphone Hcl15%Part D<11 patientsPhenothiazine8.3%Prochlorperazine Maleate100%Part D≥40 patients+ 2 more classes in this area
Metabolism & gastrointestinal
24.5%Serotonin-3 Receptor Antagonist9.6%Ondansetron Hcl100%Part D≥42 patientsCorticosteroid5.7%Prednisone100%Part D≥20 patients+ 3 more classes in this area
Blood & clotting
18.3%Factor Xa inhibitor14.4%Eliquis53%Xarelto47%Part D<11 patientsLow Molecular Weight Heparin4%Enoxaparin Sodium100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML
New England Journal of Medicine
2013 - TBC1D16 is a Rab4A GTPase activating protein that regulates receptor recycling and EGF receptor signaling
Proceedings of the National Academy of Sciences
2012 - Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf
Molecular and Cellular Biology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”